SciSparc Ltd

SPRC

Company Profile

  • Business description

    SciSparc Ltd is a specialty clinical stage pharmaceutical company. It is engaged in developing several immunotherapy products and it owns patents in the immunotherapy field. It is focused on creating and enhancing a portfolio of technologies and assets based on cannabinoid pharmaceuticals. The company has two reportable segments; development of drugs based on cannabinoid molecules to be approved by an official regulatory authority (the company’s operation); and online sales of a various range of hemp-based products including hemp gummies, hemp oil capsules, hemp gel, hemp cream, detox pills, height pills, antibacterial creams, and anti-aging creams, among other beauty and hair treatment products that are all manufactured in the United States.

  • Contact

    20 Raul Wallenberg Street
    Tower A, 2nd Floor
    Tel Aviv6971916
    ISR

    T: +972 37175777

    https://www.scisparc.com

  • Sector

    Healthcare

    Stock type

    Defensive

  • Industry

    Biotechnology

    Fiscal Year End

    31 December 2026

    Employees

    3

Stocks News & Analysis

stocks

ASX listed bank overvalued despite strong earnings

Profit beats drive shares higher for Australia’s largest asset manager.
stocks

After earnings, is Amazon a buy, a sell, or fairly valued?

After the launch of Amazon Supply Chain Services, here’s what we think of the stock.
stocks

ASX retail share expected to recover despite choppy conditions

Weakening consumer demand a temporary headwind for ASX retailer.

Morningstar Investment Ideas

Markets

Index
Last price
Change
% Change
All Ordinaries8,942.4014.500.16%
CAC 408,056.3856.19-0.69%
DAX 4024,350.2811.650.05%
Dow JONES (US)49,704.4795.310.19%
FTSE 10010,269.4336.360.36%
HKSE26,406.8413.130.05%
NASDAQ26,274.1327.050.10%
Nikkei 22562,417.88295.77-0.47%
NZX 50 Index13,210.4835.350.27%
S&P 5007,412.8413.910.19%
S&P/ASX 2008,701.8011.500.13%
SSE Composite Index4,225.0245.071.08%

Market Movers